Join the Heart Attack group to help and get support from people like you.
Heart Attack News (Page 3)
Health Disparities in Cardiometabolic Disease Seen Within Racial Subgroups
THURSDAY, Jan. 25, 2024 – Health disparities are seen in the prevalence of cardiometabolic diseases by disaggregated racial and ethnic subgroups, according to research published in the Jan. 25 issue...
Heart Disease Still America's Top Killer, Although the Death Rate Has Declined
WEDNESDAY, Jan. 24, 2024 – Heart disease remains the United States’ top cause of death, but progress is being made and more lives are being saved, a new report finds. There were 931,578 h...
Shoveling Snow Can Be a 'Perfect Storm' for Your Heart, Experts Warn
MONDAY, Jan. 15, 2024 – Snowstorms are blanketing the United States, prompting countless Americans to pick up snow shovels and clear walkways and driveways. Shoveling snow is more than a chore,...
Heart Attacks Spike During Holidays: Tips to Protect Yourself
TUESDAY, Dec. 12, 2023 – Late December is typically a time when holiday stress and winter weather can collide, creating a perfect recipe for a rise in heart attacks and stroke. Luckily, one expert...
MI Classified Into Four Stages Based on Myocardial Tissue Injury
MONDAY, Nov. 6, 2023 – In an expert consensus statement published online Oct. 28 in the Canadian Journal of Cardiology, the authors present the classification of four stages of myocardial infarction...
Adjunctive Tongxinluo Therapy Aids STEMI Outcomes
THURSDAY, Oct. 26, 2023 – In patients with ST-segment elevation myocardial infarction (STEMI), the traditional Chinese medicine Tongxinluo, as an adjunctive therapy to guideline-directed treatment,...
Million Hearts Model Cuts Five-Year Heart Attack, Stroke Risk in At-Risk Patients
WEDNESDAY, Oct. 18, 2023 – The Million Hearts Model, which encouraged and paid for cardiovascular disease (CVD) risk assessment and reduction, cut first-time heart attacks and strokes over five...
Hospitals Struggling to Reach Time-Related Treatment Goals for STEMI
FRIDAY, Oct. 13, 2023 – Challenges resulting from the COVID-19 pandemic are creating longer door-to-balloon (D2B) times for heart attack patients, according to a study presented at the annual...
Enteric-Coated, Uncoated Aspirin Have Similar Effectiveness in Heart Patients
WEDNESDAY, Oct. 11, 2023 – There is no significant difference in the primary effectiveness or safety between enteric-coated aspirin and uncoated aspirin among patients with cardiovascular disease,...
Rise in Deaths Around Retirement Age Is Behind Stagnant U.S. Life Expectancy
TUESDAY, Oct. 10, 2023 – Americans' life expectancy has been stagnant for over a decade, and much of the blame has been placed on "deaths of despair" among middle-aged adults. But a new study...
Scientists Gain Insight Into How COVID Harms the Heart
MONDAY, Oct. 2, 2023 – New research shows the COVID-19 virus can directly infect coronary arteries, inflaming fatty plaque inside them, which can increase the risk of heart disease and stroke. This...
FDA Approves Praluent (alirocumab) to Prevent Heart Attack, Stroke and Unstable Angina Requiring Hospitalization
PARIS and TARRYTOWN, NY – April 26, 2019 – The U.S. Food and Drug Administration (FDA) has approved Praluent (alirocumab) to reduce the risk of heart attack, stroke, and unstable angina requiring hos...
Victoza (liraglutide) is Approved to Reduce the Risk of Three Major Adverse Cardiovascular Events in Type 2 Diabetes Patients
PLAINSBORO, N.J., Aug. 25, 2017 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza (liraglutide) to reduce the risk of major adverse cardiovascular...
FDA Approves Expanded Indication for Brilinta to Include Long-Term Use in Patients with a History of Heart Attack
Thursday, 3 September 2015 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Brilinta (ticagrelor) tablets at a new 60mg dose to be used in patients with a...
FDA Approves Zontivity to Reduce the Risk of Heart Attacks and Stroke
May 8, 2014 – The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore...
Further information
Related drug support groups
lisinopril, metoprolol, aspirin, propranolol, warfarin, Plavix, atenolol, Coumadin, Metoprolol Succinate ER, view more... clopidogrel, Metoprolol Tartrate, Brilinta, valsartan, Lovenox, ramipril, Arthritis Pain, Diovan, nitroglycerin, ticagrelor